Liver transplantation for progressive familial intrahepatic cholestasis: Clinical and histopathological findings, outcome and impact on growth
: In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of th...
Uloženo v:
| Vydáno v: | Pediatric transplantation Ročník 11; číslo 6; s. 634 - 640 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Oxford, UK
Blackwell Publishing Ltd
01.09.2007
Blackwell |
| Témata: | |
| ISSN: | 1397-3142, 1399-3046 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | : In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score <2), and four patients had weight SD score <2. Liver transplantation were performed at the age of 43.2 ± 27 months (range 9 to 96 mfonths), 6.5 ± 3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score <2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r = 0.588 (p = 0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis. |
|---|---|
| AbstractList | In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score<2), and four patients had weight SD score<2. Liver transplantation were performed at the age of 43.2+/-27 months (range 9 to 96 months), 6.5+/-3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score<2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r=0.588 (p=0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis. In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score<2), and four patients had weight SD score<2. Liver transplantation were performed at the age of 43.2+/-27 months (range 9 to 96 months), 6.5+/-3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score<2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r=0.588 (p=0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score<2), and four patients had weight SD score<2. Liver transplantation were performed at the age of 43.2+/-27 months (range 9 to 96 months), 6.5+/-3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score<2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r=0.588 (p=0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis. : In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score <2), and four patients had weight SD score <2. Liver transplantation were performed at the age of 43.2 ± 27 months (range 9 to 96 mfonths), 6.5 ± 3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score <2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r = 0.588 (p = 0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis. In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score <2), and four patients had weight SD score <2. Liver transplantation were performed at the age of 43.2 ± 27 months (range 9 to 96 mfonths), 6.5 ± 3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1 st year only 2 patients had height SD score <2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r = 0.588 (p = 0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis. |
| Author | Arikan, C. Cakir, Murat Yuksekkaya, Hasan Ali Tumgor, Gokhan Yilmaz, Funda Kilic, Murat Aydogdu, Sema |
| Author_xml | – sequence: 1 givenname: Sema surname: Aydogdu fullname: Aydogdu, Sema organization: Department of Pediatric Gastroenterology Hepatology and Nutrition – sequence: 2 givenname: Murat surname: Cakir fullname: Cakir, Murat organization: Department of Pediatric Gastroenterology Hepatology and Nutrition – sequence: 3 givenname: C. surname: Arikan fullname: Arikan, C. organization: Department of Pediatric Gastroenterology Hepatology and Nutrition – sequence: 4 givenname: Gokhan surname: Tumgor fullname: Tumgor, Gokhan organization: Department of Pediatric Gastroenterology Hepatology and Nutrition – sequence: 5 givenname: Hasan Ali surname: Yuksekkaya fullname: Yuksekkaya, Hasan Ali organization: Department of Pediatric Gastroenterology Hepatology and Nutrition – sequence: 6 givenname: Funda surname: Yilmaz fullname: Yilmaz, Funda organization: Department of Pathology – sequence: 7 givenname: Murat surname: Kilic fullname: Kilic, Murat organization: Organ Research and Transplantation Center, Ege University, Faculty of Medicine, Bornova, İzmir, Turkiye |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18964890$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17663686$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkduO0zAQhi20iD3AKyDfwBUJdpwjEkhQ7RakChBaDnfWxHFal8QOdsp2X2KfmWlTisQNWLI8sr9_rPn_c3JindWEUM5ijuv5OuaiqiLB0jxOGCti3EkSb--Rs-PDyb4uIsHT5JSch7BmjOdpmT4gp7zIc5GX-Rm5W5if2tPRgw1DB3aE0ThLW-fp4N3S6xAQoC30pjPQUWMRXekBMUXVynU6jBBMeEFnnbFGIQK2oSsTRocQAm65v22NbYxdhmfUbUbler3nTD-AGin-uPTuZlw9JPdb6IJ-dDgvyOery-vZ22jxYf5u9noRqYzxJBKgdQZZwtIUKlUzVXIoeNtAXbZVJkCkWZJx0RQC32qWAPCs4XXK8zIVeC8uyNOpLw75Y4MzyN4EpTt0QLtNkHnJWVVUOYKPD-Cm7nUjB2968Lfyt4MIPDkAEHDOFo1UJvzhygo9rxhyryZOeReC161UZjIbDTWd5EzuopVruUtQ7hKUu2jlPlq5xQblXw2Of_xb-nKS3phO3_63Tn68vP6EFeqjSY-p6u1RD_67zAtRZPLr-7mcL7JEfPsi5BvxC1nGzR4 |
| CitedBy_id | crossref_primary_10_1007_s11894_009_0013_7 crossref_primary_10_3390_bioengineering9080392 crossref_primary_10_4285_kjt_21_0007 crossref_primary_10_1016_j_jceh_2013_10_005 crossref_primary_10_1002_lt_21470 crossref_primary_10_1111_j_1600_6143_2010_03397_x crossref_primary_10_1080_14728214_2024_2336986 crossref_primary_10_5500_wjt_v6_i2_278 crossref_primary_10_1111_j_1399_3046_2011_01514_x crossref_primary_10_1016_j_transproceed_2016_02_067 crossref_primary_10_1002_lt_21686 crossref_primary_10_1002_lt_21520 crossref_primary_10_1002_hep4_1149 crossref_primary_10_1016_j_jpedsurg_2011_08_010 crossref_primary_10_1097_MPG_0000000000002118 crossref_primary_10_1002_hep_31787 crossref_primary_10_1016_j_jhep_2009_11_012 crossref_primary_10_1016_j_transproceed_2017_03_035 crossref_primary_10_1016_j_anpedi_2009_08_005 crossref_primary_10_1111_ajt_15354 crossref_primary_10_3390_antiox11050961 crossref_primary_10_1007_s12098_011_0516_8 crossref_primary_10_1002_hep_28311 crossref_primary_10_1097_MPG_0000000000001815 crossref_primary_10_1111_petr_12741 crossref_primary_10_1016_j_transproceed_2017_06_011 crossref_primary_10_1007_s12016_014_8457_4 crossref_primary_10_1111_hepr_13222 crossref_primary_10_3390_jcm11164684 crossref_primary_10_3390_medicina57080854 crossref_primary_10_1016_j_jpedsurg_2016_11_021 crossref_primary_10_4254_wjh_v14_i1_98 crossref_primary_10_1186_s13023_021_01884_4 crossref_primary_10_1016_j_ymgme_2010_02_008 crossref_primary_10_1111_petr_14108 crossref_primary_10_14701_ahbps_21_114 crossref_primary_10_5812_ijp_117380 crossref_primary_10_1016_j_jceh_2016_05_003 crossref_primary_10_4132_jptm_2019_05_03 crossref_primary_10_1007_s10620_014_3220_5 |
| Cites_doi | 10.1053/jlts.2002.34384 10.1055/s-2001-19038 10.1097/00005176-200410000-00018 10.1002/hep.510250303 10.1111/j.1440-1746.2005.03743.x 10.1097/00005176-199705000-00011 10.1111/j.1399-3046.2004.00240.x 10.1002/hep.21287 10.1080/02724936.1995.11747792 10.1002/hep.510260121 10.1001/archpedi.1969.02100030114014 10.1016/S0022-3468(98)90435-3 10.1203/00006450-199001000-00006 10.1016/S0168-8278(03)00286-1 10.1055/s-2001-19034 10.1097/00005176-199402000-00002 10.1046/j.1440-1746.2002.02717.x 10.1034/j.1478-3231.2003.00856.x 10.1034/j.1399-3046.1999.00046.x 10.1002/hep.1840090216 |
| ContentType | Journal Article |
| Copyright | 2007 INIST-CNRS |
| Copyright_xml | – notice: 2007 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1111/j.1399-3046.2007.00722.x |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1399-3046 |
| EndPage | 640 |
| ExternalDocumentID | 17663686 18964890 10_1111_j_1399_3046_2007_00722_x PETR722 ark_67375_WNG_GL523XV3_B |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OC 29O 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RX1 SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAHHS ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE ALUQN WRC AAYXX CITATION O8X IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c5012-3aee5a52044a9cb0c81a71fdab8f953a3452513d73b0cb02aa15d1b41684313d3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 49 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000249004000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1397-3142 |
| IngestDate | Sun Nov 09 12:38:49 EST 2025 Thu Apr 03 07:00:25 EDT 2025 Mon Jul 21 09:13:52 EDT 2025 Sat Nov 29 03:28:50 EST 2025 Tue Nov 18 22:35:01 EST 2025 Wed Jan 22 17:11:56 EST 2025 Tue Nov 11 03:32:29 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Pediatrics Prognosis Growth Hepatic disease Transplantation Biliary tract disease Homotransplantation Intrahepatic cholostasis Histopathology Surgery Evolution Graft Intrahepatic Somatic growth Child Human Digestive system Family study Progressive Symptomatology Anatomic pathology Treatment Digestive diseases progressive familial intrahepatic liver transplantation |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c5012-3aee5a52044a9cb0c81a71fdab8f953a3452513d73b0cb02aa15d1b41684313d3 |
| Notes | ArticleID:PETR722 istex:8F8C453FE3F7E5D1B78505BA7D90D6A81848CC91 ark:/67375/WNG-GL523XV3-B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 17663686 |
| PQID | 68109796 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_68109796 pubmed_primary_17663686 pascalfrancis_primary_18964890 crossref_citationtrail_10_1111_j_1399_3046_2007_00722_x crossref_primary_10_1111_j_1399_3046_2007_00722_x wiley_primary_10_1111_j_1399_3046_2007_00722_x_PETR722 istex_primary_ark_67375_WNG_GL523XV3_B |
| PublicationCentury | 2000 |
| PublicationDate | September 2007 |
| PublicationDateYYYYMMDD | 2007-09-01 |
| PublicationDate_xml | – month: 09 year: 2007 text: September 2007 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: Denmark |
| PublicationTitle | Pediatric transplantation |
| PublicationTitleAlternate | Pediatr Transplant |
| PublicationYear | 2007 |
| Publisher | Blackwell Publishing Ltd Blackwell |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
| References | Knısely AS, Strautnıeks SS, Meıer Y, et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 2006: 44: 478-486. Melter M, Rodeck B, Kardorff R, et al. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 2000: 95: 3522-3528. Nagasaka H, Yorifuji T, Kosugiyama K, et al. Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: Possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone. J Pediatr Gastroenterol Nutr 2004: 39: 404-409. Kurbegov AC, Setchell KD, Haas JE, et al. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 2003: 125: 1227-1234. Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol 2002: 17: 938-948. Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997: 25: 519-523. Van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: A spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001: 21: 535-544. Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis [Byler disease (PFIC-1) and Byler syndrome]: Evidence for heterogeneity. Hepatology 1997: 26: 155-164. Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003: 23: 315-322. Heubi JE, Hollis BW, Tsang RC. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res 1990: 27: 26-31. Egawa H, Yorifuji T, Sumazaki R, et al. Intractable diarrhea after liver transplantation for Byler's disease: Successful treatment with bile adsorptive resin. Liver Transpl 2002: 8: 714-716. Heubi JE, Hollis BW, Specker B, et al. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 1989: 9: 258-264. Shneider BL. Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy. Pediatr Transplant 2004: 8: 609-612. Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969: 117: 112-124. Thompson R, Strautnieks S. BSEP: Function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001: 21: 545-550. Lykavieris P, Van Mil S, Cresteil D, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003: 39: 447-452. Naveh Y, Bassan L, Rosenthal E, et al. Progressive familial intrahepatic cholestasis among the Arab population in Israel. J Pediatr Gastroenterol Nutr 1997: 24: 548-554. Kagalwalla AF, Al Amir AR, Khalifa A, et al. Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children. Ann Trop Paediatr 1995: 15: 321-327. Wanty C, Joomye R, Van Hoorebeek N, et al. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol Belg 2004: 67: 313-319. Harris MJ, Le Couteur DG, Arias IM. Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters. J Gastroenterol Hepatol 2005: 20: 807-817. Ismail H, Kalicinski P, Markiewicz M, et al. Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion. Pediatr Transplant 1999: 3: 219-224. Alonso EM, Snover DC, Montag A, et al. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994: 18: 128-133. Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R, Loret-de-Mola O, Nahmad M, Burnweit CA. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus. J Pediatr Surg 1998: 33: 220-224. 2002; 17 1990; 27 1995; 15 2004; 39 2006; 44 1997; 26 2004; 8 1997; 25 2004; 67 1989; 9 1997; 24 2002; 8 2000; 95 2005; 20 2003; 39 1999; 3 1994; 18 1969; 117 2003; 125 1998; 33 2003; 23 2001; 21 Melter M (e_1_2_6_21_2) 2000; 95 Kurbegov AC (e_1_2_6_20_2) 2003; 125 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_18_2 Wanty C (e_1_2_6_9_2) 2004; 67 e_1_2_6_19_2 e_1_2_6_4_2 e_1_2_6_3_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_12_2 e_1_2_6_24_2 e_1_2_6_13_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_10_2 e_1_2_6_22_2 e_1_2_6_11_2 e_1_2_6_16_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 |
| References_xml | – reference: Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol 2002: 17: 938-948. – reference: Heubi JE, Hollis BW, Specker B, et al. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 1989: 9: 258-264. – reference: Nagasaka H, Yorifuji T, Kosugiyama K, et al. Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: Possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone. J Pediatr Gastroenterol Nutr 2004: 39: 404-409. – reference: Kagalwalla AF, Al Amir AR, Khalifa A, et al. Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children. Ann Trop Paediatr 1995: 15: 321-327. – reference: Kurbegov AC, Setchell KD, Haas JE, et al. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 2003: 125: 1227-1234. – reference: Egawa H, Yorifuji T, Sumazaki R, et al. Intractable diarrhea after liver transplantation for Byler's disease: Successful treatment with bile adsorptive resin. Liver Transpl 2002: 8: 714-716. – reference: Wanty C, Joomye R, Van Hoorebeek N, et al. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol Belg 2004: 67: 313-319. – reference: Heubi JE, Hollis BW, Tsang RC. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res 1990: 27: 26-31. – reference: Shneider BL. Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy. Pediatr Transplant 2004: 8: 609-612. – reference: Thompson R, Strautnieks S. BSEP: Function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001: 21: 545-550. – reference: Harris MJ, Le Couteur DG, Arias IM. Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters. J Gastroenterol Hepatol 2005: 20: 807-817. – reference: Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969: 117: 112-124. – reference: Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R, Loret-de-Mola O, Nahmad M, Burnweit CA. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus. J Pediatr Surg 1998: 33: 220-224. – reference: Knısely AS, Strautnıeks SS, Meıer Y, et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 2006: 44: 478-486. – reference: Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis [Byler disease (PFIC-1) and Byler syndrome]: Evidence for heterogeneity. Hepatology 1997: 26: 155-164. – reference: Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997: 25: 519-523. – reference: Naveh Y, Bassan L, Rosenthal E, et al. Progressive familial intrahepatic cholestasis among the Arab population in Israel. J Pediatr Gastroenterol Nutr 1997: 24: 548-554. – reference: Lykavieris P, Van Mil S, Cresteil D, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003: 39: 447-452. – reference: Melter M, Rodeck B, Kardorff R, et al. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 2000: 95: 3522-3528. – reference: Ismail H, Kalicinski P, Markiewicz M, et al. Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion. Pediatr Transplant 1999: 3: 219-224. – reference: Alonso EM, Snover DC, Montag A, et al. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994: 18: 128-133. – reference: Van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: A spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001: 21: 535-544. – reference: Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003: 23: 315-322. – volume: 20 start-page: 807 year: 2005 end-page: 817 article-title: Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters publication-title: J Gastroenterol Hepatol – volume: 24 start-page: 548 year: 1997 end-page: 554 article-title: Progressive familial intrahepatic cholestasis among the Arab population in Israel publication-title: J Pediatr Gastroenterol Nutr – volume: 39 start-page: 447 year: 2003 end-page: 452 article-title: Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch‐up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation publication-title: J Hepatol – volume: 15 start-page: 321 year: 1995 end-page: 327 article-title: Progressive familial intrahepatic cholestasis (Byler’s disease) in Arab children publication-title: Ann Trop Paediatr – volume: 27 start-page: 26 year: 1990 end-page: 31 article-title: Bone disease in chronic childhood cholestasis. II. Better absorption of 25‐OH vitamin D than vitamin D in extrahepatic biliary atresia publication-title: Pediatr Res – volume: 17 start-page: 938 year: 2002 end-page: 948 article-title: Extrahepatic manifestations of cholestasis publication-title: J Gastroenterol Hepatol – volume: 26 start-page: 155 year: 1997 end-page: 164 article-title: Genetic and morphological findings in progressive familial intrahepatic cholestasis [Byler disease (PFIC‐1) and Byler syndrome]: Evidence for heterogeneity publication-title: Hepatology – volume: 3 start-page: 219 year: 1999 end-page: 224 article-title: Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion publication-title: Pediatr Transplant – volume: 39 start-page: 404 year: 2004 end-page: 409 article-title: Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: Possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone publication-title: J Pediatr Gastroenterol Nutr – volume: 8 start-page: 714 year: 2002 end-page: 716 article-title: Intractable diarrhea after liver transplantation for Byler’s disease: Successful treatment with bile adsorptive resin publication-title: Liver Transpl – volume: 44 start-page: 478 year: 2006 end-page: 486 article-title: Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency publication-title: Hepatology – volume: 67 start-page: 313 year: 2004 end-page: 319 article-title: Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy publication-title: Acta Gastroenterol Belg – volume: 125 start-page: 1227 year: 2003 end-page: 1234 publication-title: Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile – volume: 25 start-page: 519 year: 1997 end-page: 523 article-title: Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis publication-title: Hepatology – volume: 8 start-page: 609 year: 2004 end-page: 612 article-title: Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy publication-title: Pediatr Transplant – volume: 18 start-page: 128 year: 1994 end-page: 133 article-title: Histologic pathology of the liver in progressive familial intrahepatic cholestasis publication-title: J Pediatr Gastroenterol Nutr – volume: 21 start-page: 545 year: 2001 end-page: 550 article-title: BSEP: Function and role in progressive familial intrahepatic cholestasis publication-title: Semin Liver Dis – volume: 23 start-page: 315 year: 2003 end-page: 322 article-title: Genetic cholestasis, causes and consequences for hepatobiliary transport publication-title: Liver Int – volume: 117 start-page: 112 year: 1969 end-page: 124 article-title: Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred publication-title: Am J Dis Child – volume: 33 start-page: 220 year: 1998 end-page: 224 article-title: Ileal exclusion for Byler’s disease: An alternative surgical approach with promising early results for pruritus publication-title: J Pediatr Surg – volume: 21 start-page: 535 year: 2001 end-page: 544 article-title: FIC1 disease: A spectrum of intrahepatic cholestatic disorders publication-title: Semin Liver Dis – volume: 9 start-page: 258 year: 1989 end-page: 264 article-title: Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism publication-title: Hepatology – volume: 95 start-page: 3522 year: 2000 end-page: 3528 publication-title: Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients – ident: e_1_2_6_16_2 doi: 10.1053/jlts.2002.34384 – ident: e_1_2_6_23_2 doi: 10.1055/s-2001-19038 – ident: e_1_2_6_15_2 doi: 10.1097/00005176-200410000-00018 – ident: e_1_2_6_8_2 doi: 10.1002/hep.510250303 – volume: 67 start-page: 313 year: 2004 ident: e_1_2_6_9_2 article-title: Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy publication-title: Acta Gastroenterol Belg – ident: e_1_2_6_2_2 doi: 10.1111/j.1440-1746.2005.03743.x – volume: 95 start-page: 3522 year: 2000 ident: e_1_2_6_21_2 publication-title: Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients – volume: 125 start-page: 1227 year: 2003 ident: e_1_2_6_20_2 publication-title: Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile – ident: e_1_2_6_14_2 doi: 10.1097/00005176-199705000-00011 – ident: e_1_2_6_18_2 doi: 10.1111/j.1399-3046.2004.00240.x – ident: e_1_2_6_24_2 doi: 10.1002/hep.21287 – ident: e_1_2_6_10_2 doi: 10.1080/02724936.1995.11747792 – ident: e_1_2_6_3_2 doi: 10.1002/hep.510260121 – ident: e_1_2_6_4_2 doi: 10.1001/archpedi.1969.02100030114014 – ident: e_1_2_6_19_2 doi: 10.1016/S0022-3468(98)90435-3 – ident: e_1_2_6_13_2 doi: 10.1203/00006450-199001000-00006 – ident: e_1_2_6_17_2 doi: 10.1016/S0168-8278(03)00286-1 – ident: e_1_2_6_22_2 doi: 10.1055/s-2001-19034 – ident: e_1_2_6_11_2 doi: 10.1097/00005176-199402000-00002 – ident: e_1_2_6_6_2 doi: 10.1046/j.1440-1746.2002.02717.x – ident: e_1_2_6_5_2 doi: 10.1034/j.1478-3231.2003.00856.x – ident: e_1_2_6_7_2 doi: 10.1034/j.1399-3046.1999.00046.x – ident: e_1_2_6_12_2 doi: 10.1002/hep.1840090216 |
| SSID | ssj0016484 |
| Score | 2.0264375 |
| Snippet | : In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive... In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 634 |
| SubjectTerms | Biological and medical sciences Bone Density Child Child, Preschool Cholestasis, Intrahepatic - complications Cholestasis, Intrahepatic - genetics Cholestasis, Intrahepatic - pathology Cholestasis, Intrahepatic - surgery Disease Progression Female Gastroenterology. Liver. Pancreas. Abdomen General aspects Growth Humans Infant liver transplantation Liver Transplantation - adverse effects Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Other diseases. Semiology progressive familial intrahepatic Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Treatment Outcome |
| Title | Liver transplantation for progressive familial intrahepatic cholestasis: Clinical and histopathological findings, outcome and impact on growth |
| URI | https://api.istex.fr/ark:/67375/WNG-GL523XV3-B/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1399-3046.2007.00722.x https://www.ncbi.nlm.nih.gov/pubmed/17663686 https://www.proquest.com/docview/68109796 |
| Volume | 11 |
| WOSCitedRecordID | wos000249004000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library customDbUrl: eissn: 1399-3046 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016484 issn: 1397-3142 databaseCode: DRFUL dateStart: 19990101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BghCX8iw1j7AHxAkj2-v1ernxaMohRFXVltxW-3IbETkoTkp_Bb-ZmbWTEtRDhbhEkdYTeyff7I5nZr8h5LXJZWYyncaZqIo4L6yLpXNFXAGgPWxPWoaY7ulIjMflZCIPu_onPAvT8kNsAm5oGWG9RgPXptk2cthcY8zsrZkIRZa9A3-ynwGM8x7pfz4anow2OYUiL9sWtxIjc_lfdT3X_tbWZtVHvV9i8aRuQH9V2_jiOs9029ENO9Xw_v-c4wOy0_mr9EMLsIfklq8fkbtfu4z8Y_JrhIUddBk40me6PchUU3CFaSj9wirbC09DHAWgTqcYTD73WMdtKS69MCPdTJv3tGMonVFdOxpokLFb8nptpiG5Xp81b-l8tYR5-HBde8iTwh3PFvOfy_Mn5GS4f_zpS9z1eIgtT5AvUXvPNc-SPNfSmsSWqRZp5bQpK8mZZph3TZkTDMZMkmmdcpcacCNLcH2YY7ukV89rv0eo5U57WK21M3nOrdTMBhnD4LPkJiJi_Wcq2xGgYx-OmfrjRQjUrVDd2J4TM_OgbnUZkXQj-aMlAbmBzJuAl42AXnzHIjrB1bfxgToY8YxNTpn6GJHBFqCu7lBKgKxMIvJqjTAFto8JHV37-apRyCUnhSwi8rQF3pWsAE-yKGGkCPi68WOrw_3jI_j27F8Fn5N7bfgby_BekN5ysfIvyR17sZw2iwG5LSbloLPM39taN4c |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZQi4CX8ZuFweYHxBNBSRwnMW8D1g2RVdPUjb5Zju1sFVU6Nem2v4K_mTsn7Sjaw4R4qSo518TX7-zL3fk7Qt4VsYiKSIV-lJaJHyfa-MKYxC8B0Ba2JyVcTPc0T4fDbDwWR107IDwL0_JDrAJuaBluvUYDx4D0upXD7upjam9JRZhG0UdwKPsxoIr3SP_r8eAkXyUVkjhre9wKDM3FfxX23Ppba7tVHxV_jdWTqgYFlm3ni9tc03VP121Vg8f_dZJPyEbnsdLdFmJPyT1bPSMPDruc_HPyK8fSDto4lvSpao8yVRScYeqKv7DO9tJSF0kBsNMJhpPPLVZya4qLL0xJ1ZP6E-04SqdUVYY6ImTsl7xcnalLr1dn9Qc6WzQwEeuua495Urjj2Xx21Zy_ICeDvdGXA7_r8uBrHiBjorKWKx4FcayELgKdhSoNS6OKrBScKYaZ15CZlMFYEURKhdyEBTiSGTg_zLCXpFfNKrtJqOZGWVivlSnimGuhmHYyBYPPjBceSZf_ptQdBTp24pjKP16FQN0S1Y0NOjE3D-qW1x4JV5IXLQ3IHWTeO8CsBNT8J5bRpVz-GO7L_ZxHbHzK5GePbK8h6uYOmQDMisAjO0uISbB-TOmoys4WtUQ2OZGKxCOvWuTdyKbgSyYZjCQOYHd-bHm0NzqGb6__VXCHPDwYHeYy_zb8vkUetcFwLMp7Q3rNfGHfkvv6spnU8-3OQH8DJbY6jw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQiiZe-P4IH5sfEE8EJXGcxLwBWwciVNW0jb5Zju1sFVU6NenYX8HfzJ2ddhTtYUK8VJWca-Lr7-zL3fl3hLyuUpFUiYrDJK-zMM20CYUxWVgDoC1sT0q4mO5JmY9GxWQixn07IDwL4_kh1gE3tAy3XqOB23NTb1o57K4hpvZWVIR5krwDh3KQcpGBlQ72DofH5TqpkKWF73ErMDSX_lXYc-1vbexWA1T8JVZPqhYUWPvOF9e5ppuertuqhvf-6yTvk7u9x0o_eIg9ILds85Bsf-tz8o_IrxJLO2jnWNJnyh9laig4w9QVf2Gd7YWlLpICYKdTDCefWazk1hQXX5iSaqfte9pzlM6oagx1RMjYL3m1OlOXXm9O27d0vuxgItZd5495Urjj6WL-szt7TI6H-0efPod9l4dQ8wgZE5W1XPEkSlMldBXpIlZ5XBtVFbXgTDHMvMbM5AzGqihRKuYmrsCRLMD5YYY9IVvNvLHPCNXcKAvrtTJVmnItFNNOpmLwWfAqIPnq35S6p0DHThwz-cerEKhborqxQSfm5kHd8jIg8Vry3NOA3EDmjQPMWkAtfmAZXc7l99GBPCh5wiYnTH4MyM4Goq7uUAjArIgCsruCmATrx5SOaux82UpkkxO5yALy1CPvSjYHXzIrYCRzALvxY8vx_tEhfHv-r4K7ZHu8N5Tll9HXF-SOj4VjTd5LstUtlvYVua0vumm72Ont8zdawjoK |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liver+transplantation+for+progressive+familial+intrahepatic+cholestasis%3A+clinical+and+histopathological+findings%2C+outcome+and+impact+on+growth&rft.jtitle=Pediatric+transplantation&rft.au=Aydogdu%2C+Sema&rft.au=Cakir%2C+Murat&rft.au=Arikan%2C+C&rft.au=Tumgor%2C+Gokhan&rft.date=2007-09-01&rft.issn=1397-3142&rft.volume=11&rft.issue=6&rft.spage=634&rft_id=info:doi/10.1111%2Fj.1399-3046.2007.00722.x&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1397-3142&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1397-3142&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1397-3142&client=summon |